TRP_1170x120_3-8-19

Healthcare Distribution Alliance (HDA)

HDA’s statement on Inspector General’s DEA report

HDA’s statement on Inspector General’s DEA report

ARLINGTON, Va. — In response to the release of the U.S. Department of Justice Office of the Inspector General’s Review of the Drug Enforcement Administration’s (DEA) Regulatory and Enforcement Efforts to Control the Diversion of Opioids, John Parker, senior vice president of communications with the Healthcare Distribution Alliance (HDA) released the following statement last week: “Today’s

HDA issues statement on Inspector General’s DEA report

HDA issues statement on Inspector General’s DEA report

ARLINGTON, Va. —  In response to the release of the U.S. Department of Justice Office of the Inspector General’s Review of the Drug Enforcement Administration’s (DEA) Regulatory and Enforcement Efforts to Control the Diversion of Opioids, John Parker, senior vice president of communications with the Healthcare Distribution Alliance (HDA) released the following statement. “Today’s report by the

HDA honors manufacturers with 2019 DIANA Awards

HDA honors manufacturers with 2019 DIANA Awards

ORLANDO, Fla. — The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The honorees were formally recognized during the DIANA and Nexus Awards dinner at the HDA 2019 Business and Leadership Conference in Orlando, Fla. This year marks the DIANA Awards’

Novartis and Sandoz honored with Power of Partnership Award

Novartis and Sandoz honored with Power of Partnership Award

STAMFORD, Conn. – Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Novartis and its Sandoz division, in recognition of their outstanding commitment to increasing access to health care around the world. Americares senior vice president of global programs Dr. E. Anne Peterson presented the award

HDA issues statement on enhanced DEA ARCOS data monitoring

HDA issues statement on enhanced DEA ARCOS data monitoring

ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) president and chief executive officer John Gray issued  the following statement in response to the Drug Enforcement Administration’s (DEA) announcement of an enhanced data tool to support additional information sharing with pharmaceutical distributors and manufacturers: “The DEA has taken an important step to enhance data transparency and address a

HDA announces Drew and Mauch to lead board of directors

HDA announces Drew and Mauch to lead board of directors

ARLINGTON, Va.  — The Healthcare Distribution Alliance (HDA) announced today the election of Greg Drew, president of Value Drug Company, as chairman of HDA’s board of directors. Robert Mauch, executive vice president and group president at AmerisourceBergen Corporation, was elected vice chairman. The new leadership was announced at the HDA Annual Board and Membership Meeting. Drew,

AAOA releases toolkit to educate on opioid abuse and misuse

AAOA releases toolkit to educate on opioid abuse and misuse

ARLINGTON, Va. — Allied Against Opioid Abuse (AAOA), a national initiative to help prevent prescription opioid abuse and misuse through education, has created a pharmacy toolkit to equip pharmacists with resources to engage and educate patients about the safe use, storage and disposal of pain medicines. AAOA, along with its founding member, the Healthcare Distribution Alliance (HDA),

HDA Traceability Seminar scheduled for October

HDA Traceability Seminar scheduled for October

ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) will convene pharmaceutical supply chain industry leaders at its Traceability Seminar, October 17 to 19 in Washington, D.C. The 2018 seminar will educate attendees about where the pharmaceutical supply chain is in relation to achieving full implementation of the Drug Supply Chain Security Act (DSCSA) in 2023; what to expect

HDA issues statement on FDA to examine prescription drug importation

HDA issues statement on FDA to examine prescription drug importation

ARLINGTON, Va. —Healthcare Distribution Alliance (HDA) president and chief executive officer John Gray released the following statement on the Department of Health and Human Services’ (HHS) recent directive to establish a Food and Drug Administration (FDA) work group to examine prescription drug importation policies: “HDA and the nation’s primary pharmaceutical distributors appreciate the Trump administration’s efforts

HDA 2018 DIANA Awards applaud industry excellence

HDA 2018 DIANA Awards applaud industry excellence

COLORADO SPRINGS, Colo. — The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The awards were distributed at the HDA 2018 Business and Leadership Conference here. The DIANA Awards have been a symbol of excellence in the pharmaceutical supply chain since 1959.

Americares honors Mylan with Power of Partnership Award

Americares honors Mylan with Power of Partnership Award

STAMFORD, Conn. – Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Mylan, in recognition of its outstanding commitment to increasing access to health care around the world. Mylan is among Americares most dedicated and longstanding supporters, providing pharmaceutical products for the organization’s health programs for people affected